COVID-19 vaccine induced Axillary and Pectoral Lymphadenopathy on PET scan

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused the ongoing global pandemic. It can manifest a wide range of complications depending upon the severity of infection and comorbidities of the patient. Vaccines are very important mea...

Full description

Saved in:
Bibliographic Details
Published inRadiology case reports Vol. 16; no. 7; pp. 1819 - 1821
Main Authors Singh, Balraj, Kaur, Parminder, Kumar, Vinod, Maroules, Michael
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier Inc 01.07.2021
Elsevier
Subjects
Adverse events
Case Report
COVID-19
COVID-19 vaccine
SARS-CoV-2, Lymphadenopathy
Severe acute respiratory syndrome-coronavirus-2
Side effects
COVID-19
COVID-19 vaccine
Side effects
SARS-CoV-2, Lymphadenopathy
Adverse events
Severe acute respiratory syndrome-coronavirus-2
Lymphadenopathy
SARS-CoV-2
severe acute respiratory syndrome-coronavirus-2
side effects
adverse events
Online AccessGet full text

Cover

More Information
Summary:Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused the ongoing global pandemic. It can manifest a wide range of complications depending upon the severity of infection and comorbidities of the patient. Vaccines are very important measure to provide protection against COVID‐19. We report a case of 72-year-old female with past medical history of hypertension and diabetes mellitus who underwent imaging with positron emission tomography (PET) scan imaging for staging of her small cell urinary bladder cancer and was found to have hypermetabolic uptake in the deltoid muscle of the left shoulder and hypermetabolic left axillary and pectoral lymph nodes due to mRNA BNT-162b2 (Pfizer-BioNTech COVID-19 vaccine) vaccine administrated 3 days ago prior to PET scan.
ISSN:1930-0433
1930-0433
DOI:10.1016/j.radcr.2021.04.053